Limited Sampling Strategy of Partial Area Under the Concentration–Time Curves to Estimate Midazolam Systemic Clearance for Cytochrome P450 3A Phenotyping-Reference-Cited by-同舟云学术

Limited Sampling Strategy of Partial Area Under the Concentration–Time Curves to Estimate Midazolam Systemic Clearance for Cytochrome P450 3A Phenotyping

Published:2015-02 Issue:1 Volume:37 Page:84-89
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Masters Joanna C.,Harano Denise M.,Greenberg Howard E.,Tsunoda Shirley M.,Jang In-Jin,Ma Joseph D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference38 articles.

1. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.;Streetman;Pharmacogenetics,2000

2. . The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.;Bjornsson;J Clin Pharmacol,2003

3. Cytochrome P-450 3A4: regulation and role in drug metabolism.;Guengerich;Annu Rev Pharmacol Toxicol,1999

4. . Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.;Tsunoda;Clin Pharmacol Ther,1999

5. . Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.;Thummel;J Pharmacol Exp Ther,1994

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of balanced propofol and midazolam in upper gastrointestinal endoscopy for sedation in cirrhotic patients;Journal of the Pakistan Medical Association;2020-10-21

2. Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate;Frontiers in Pharmacology;2019-09-27

3. The Prediction of the Area under the Curve and Clearance of Midazolam from Single-Point Plasma Concentration and Urinary Excretion in Healthy Volunteers;Biological and Pharmaceutical Bulletin;2019-09-01

4. Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film;European Journal of Pharmaceutical Sciences;2019-07

5. Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults;The Journal of Clinical Pharmacology;2019-05-03